RT Journal Article
SR Electronic
T1 Angle-angle diagrams in the assessment of locomotion in persons with multiple sclerosis: A preliminary study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.09.22268813
DO 10.1101/2022.01.09.22268813
A1 Giminiani, Riccardo Di
A1 Lorenzo, Davide Di
A1 Russo, Luca
A1 Greca, Stefano La
A1 Masedu, Francesco
A1 Totaro, Rocco
A1 Padua, Elvira
YR 2022
UL http://medrxiv.org/content/early/2022/06/10/2022.01.09.22268813.abstract
AB Gait analysis is clinically relevant in persons with multiple sclerosis (PwMS) and consists of several joint angular displacement-time relationships and spatiotemporal parameters. However, it lacks representation by means of diagrams in which knee angle-hip angle and knee angle-ankle angle variations are plotted against each other at the same instants of time. Three-dimensional kinematic analysis was performed on 20 subjects (10 PwMS/10 healthy controls, HCs), and the knee-angle/hip-angle and knee-angle/ankle-angle diagrams of both lower limbs were determined in the sagittal plane while walking on a motorized treadmill. The area (a quantifier of conjoint range of motion) and the perimeter (a quantifier of coordination) of angle-angle diagram loops were calculated. PwMS showed reduced knee-angle/ankle-angle loops compared to HCs (P<0.05, ES = 0.80), whereas the hip-angle/ankle-angle loops between the PwMS and HCs was not significant (P> 0.05). Similarly, the activation of leg muscles showed significant differences between PwMS and HCs (p ranged from 0.05-to 0.001; ES ranged from 1.30 to 1.89). The results indicate that the proposed knee-angle/hip-angle diagram is feasible and could be applied as a reliable tool in future studies aimed at assessing the acute and long-term effects of specific exercise programmes and/or pharmacological treatment in PwMS.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The local ethics committee named Internal Review Board of the University of L'Aquila, Abruzzo-Italy (Protocol number 13/2021; www.univaq.it/en/section.php?id=1527) approved the study. Following all the participants gave their written informed consent according to the Helsinki declaration.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors